Detalhe da pesquisa
1.
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.
Haematologica
; 107(2): 467-477, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33406815
2.
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
Br J Haematol
; 191(1): 107-114, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32427352
3.
The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
Ann Hematol
; 97(10): 1925-1932, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29926157
4.
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Br J Haematol
; 176(1): 124-130, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27748513
5.
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
Am J Hematol
; 97(2): E75-E78, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34861054
6.
Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
Eur J Haematol
; 97(4): 361-70, 2016 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26818147
7.
Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
Am J Hematol
; 90(11): 1008-12, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26228763
8.
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.
Br J Haematol
; 167(1): 121-6, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24992281
9.
Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study.
Br J Haematol
; 163(4): 520-7, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24111905
10.
Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death.
Blood Cells Mol Dis
; 50(4): 241-6, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23337255
11.
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major.
Blood Cells Mol Dis
; 51(2): 85-8, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23628348
12.
Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.
J Cardiovasc Magn Reson
; 15: 1, 2013 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-23324167
13.
Feasibility, reproducibility, and reliability for the T*2 iron evaluation at 3 T in comparison with 1.5 T.
Magn Reson Med
; 68(2): 543-51, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22127999
14.
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.
Am J Hematol
; 87(7): 732-3, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22622672
15.
The The use of oral glucose-lowering agents (GLAs) in ß-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.
Acta Biomed
; 93(2): e2022162, 2022 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35546014
16.
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.
Front Med (Lausanne)
; 9: 832154, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35372393
17.
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.
Hemoglobin
; 35(3): 206-16, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21599433
18.
Paraplegia in a thalassaemic patient with short stature.
Pediatr Endocrinol Rev
; 8 Suppl 2: 340-4, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21705991
19.
The Prevalence of glucose dysregulations (GDs) in patients with ß-thalassemias in different countries: A preliminary ICET-A survey.
Acta Biomed
; 92(3): e2021240, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34212897
20.
Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre study.
Blood Transfus
; 19(2): 168-176, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33000750